| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Analysis of Time to Improvement in Oxygenation in Japanese Preterm and Late Preterm or Term Neonates With Hypoxic Respiratory Failure and Pulmonary Hypertension
|
Rhine, William D.
|
|
2019
|
41 |
5 |
p. 910-919
|
artikel
|
| 2 |
Comparative Cost-utility Analysis Between Aprepitant- and Fosaprepitant-containing Regimens To Prevent Chemotherapy-induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy in Japan
|
Kashiwa, Munenobu
|
|
2019
|
41 |
5 |
p. 929-942
|
artikel
|
| 3 |
Computational Drug Discovery in Chemotherapy-induced Alopecia via Text Mining and Biomedical Databases
|
Zhang, Nanyang
|
|
2019
|
41 |
5 |
p. 972-980.e8
|
artikel
|
| 4 |
Daratumumab Split First Versus Single Dosing Schedule Among Patients With Multiple Myeloma Treated in a US Community Oncology Setting: A Retrospective Observational Study
|
Rifkin, Robert
|
|
2019
|
41 |
5 |
p. 866-881.e7
|
artikel
|
| 5 |
Editorial Board
|
|
|
2019
|
41 |
5 |
p. ii-iii
|
artikel
|
| 6 |
Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
|
Williams PhD, Marshall V.
|
|
2019
|
41 |
5 |
p. 848-863
|
artikel
|
| 7 |
Evaluating Benefit-risk Decision-making in Spinal Muscular Atrophy: A First-ever Study to Assess Risk Tolerance in the SMA Patient Community
|
Cruz, Rosángel
|
|
2019
|
41 |
5 |
p. 943-960.e4
|
artikel
|
| 8 |
In Search of Effective Treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
|
Theoharides, Theoharis C.
|
|
2019
|
41 |
5 |
p. 796-797
|
artikel
|
| 9 |
Insulin Autoimmune Syndrome Diagnosis and Therapy in a Single Chinese Center
|
Yuan, Tao
|
|
2019
|
41 |
5 |
p. 920-928
|
artikel
|
| 10 |
Letter to the Editor: Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: Definitions, Similarities, and Differences
|
Twisk, Frank N.M.
|
|
2019
|
41 |
5 |
p. 1002-1003
|
artikel
|
| 11 |
Musings on Melanoma
|
Shader, Richard I.
|
|
2019
|
41 |
5 |
p. 791-793
|
artikel
|
| 12 |
Optimizing Patient Selection to Maximize Drug Efficacy: the Expanding Role of Pharmacogenomics in the Clinical Development of Pembrolizumab for the Treatment of Non-small Cell Lung Cancer
|
Dello Russo, Cinzia
|
|
2019
|
41 |
5 |
p. 982-991
|
artikel
|
| 13 |
Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary
|
Richman, Spencer
|
|
2019
|
41 |
5 |
p. 798-805
|
artikel
|
| 14 |
Pharmacokinetics and Pharmacodynamics of Once-daily Prolonged-release Tacrolimus in Liver Transplant Recipients
|
Allard, Marie
|
|
2019
|
41 |
5 |
p. 882-896.e3
|
artikel
|
| 15 |
Pharmacokinetics and Tolerability of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate and Glycopyrronium/Formoterol Fumarate Dihydrate Metered Dose Inhalers in Healthy Chinese Adults: A Randomized, Double-blind, Parallel-group Study
|
Chen, Qian
|
|
2019
|
41 |
5 |
p. 897-909.e1
|
artikel
|
| 16 |
Pharmacokinetics of Ketamine at Dissociative Doses in an Adult Patient With Refractory Status Asthmaticus Receiving Extracorporeal Membrane Oxygenation Therapy
|
Lam, Edwin
|
|
2019
|
41 |
5 |
p. 994-999
|
artikel
|
| 17 |
Pharmacokinetics of Single Doses of BI 425809 in Healthy Chinese and Japanese Subjects: A Randomized Study
|
Tsuda, Yasuhiro
|
|
2019
|
41 |
5 |
p. 961-971
|
artikel
|
| 18 |
Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome
|
Rekeland, Ingrid G.
|
|
2019
|
41 |
5 |
p. 806-814
|
artikel
|
| 19 |
Searching for Serum Antibodies to Neuronal Proteins in Patients With Myalgic Encephalopathy/Chronic Fatigue Syndrome
|
Giannoccaro, Maria Pia
|
|
2019
|
41 |
5 |
p. 836-847
|
artikel
|
| 20 |
Table of Contents
|
|
|
2019
|
41 |
5 |
p. iv-v
|
artikel
|
| 21 |
Treatment Avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Split-gender Pharmacogenomic Study of Gene-expression Modules
|
Jeffrey, Mary G.
|
|
2019
|
41 |
5 |
p. 815-835.e6
|
artikel
|
Tijdschrift beschrijving